For most patients, Azstarys and Pitolisant offer very similar levels of effectiveness. Both drugs work well in symptom control, with no significant advantage in terms of long-term results. The primary difference may be in how quickly they provide relief, but in many cases, either drug can effectively manage the issue. Both drugs are considered equally viable options depending on the patient's specific needs.

On the other hand, Pitolisant may be the safer option for long-term use. It has a well-documented safety profile, particularly for older patients or those with underlying medical conditions. Pitolisant is known for being more gentle on the liver and kidneys, making it a better option for patients who are at higher risk for organ damage.

Additionally, Pitolisant has fewer restrictions on its use with other medications, which can be a significant benefit for patients requiring polypharmacy. Although both drugs are generally safe, Pitolisant's safety profile may make it more appropriate for certain patient populations.

Azstarys is the better choice for patients concerned about addiction, as it has a significantly lower risk of dependency or misuse. Unlike Pitolisant, which has a higher potential for abuse due to its effects on the brain’s reward system, Azstarys has been shown to have minimal addictive properties when used as prescribed. This makes Azstarys a more suitable option for patients with a history of substance abuse or for those who want to avoid any risk of developing an addiction.

Both Azstarys and Pitolisant are relatively easy to use, with each drug offering straightforward dosing regimens. While Azstarys may be simpler with a once-daily schedule, Pitolisant’s flexibility in dosage forms allows for personalization. For most patients, both drugs offer an equally manageable way to adhere to treatment, making ease of use a non-decisive factor when choosing between them.

Azstarys has fewer contraindications compared to Pitolisant, making it a more versatile option for patients with various health conditions. It is generally safe for use in patients with multiple comorbidities and doesn’t interact significantly with other medications. Additionally, Azstarys has fewer restrictions when it comes to pre-existing conditions such as liver disease or hypertension, making it more accessible for a broader range of patients.

Both Azstarys and Pitolisant have their advantages, and the best choice ultimately depends on the patient's specific needs. Azstarys may be ideal for those requiring fast relief and simplicity in treatment, while Pitolisant may be better suited for those seeking consistent, long-term management. Both drugs have similar safety profiles, and addiction risk is minimal for both. For most patients, the decision between Azstarys and Pitolisant comes down to treatment goals and individual preferences.